Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Sortiert nach
Einfacher Volltextzugriff von (fast) überall
Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)
Annals of oncology, 2019-07, Vol.30, p.iv133-iv133
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
A High Throughput Cell-based Screen Identifies Compounds That Inhibit the Viral Oncoprotein E6 in Human Papillomavirus-positive Cancers
International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S166-S166
2012
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
RIG-1-Like Receptor LGP2 Protects Tumor Cells From Ionizing Radiation
International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S149-S149
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
1015TiP Ramucirumab in patients with advanced hepatocellular carcinoma and elevated alpha fetoprotein following a non-sorafenib based systemic therapy: An expansion cohort of the phase III REACH-2 study
Annals of oncology, 2020-09, Vol.31, p.S702-S702
2020
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
O-021Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH)
Annals of oncology, 2019-07, Vol.30 (Supplement_4)
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
758P - Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
Annals of oncology, 2019-10, Vol.30, p.v293-v294
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
Annals of oncology, 2019-10, Vol.30, p.v293-v294
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
758PRamucirumab in patients with advanced hepatocellular carcinoma (HCC) and elevated alpha fetoprotein (AFP): An exposure-response analysis
Annals of oncology, 2019-10, Vol.30 (Supplement_5)
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
753PPrognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
Annals of oncology, 2019-10, Vol.30 (Supplement_5)
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
Annals of oncology, 2019-10, Vol.30, p.v289-v290
2019
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
753P - Prognostic and predictive value of baseline alpha-fetoprotein (AFP) in patients with advanced hepatocellular carcinoma (HCC) treated with ramucirumab from two phase III studies (REACH, REACH-2)
Annals of oncology, 2019-10, Vol.30, p.v289-v290
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
P3.01-071 Randomized Phase 1b/3 Study of Erlotinib + Ramucirumab in Untreated EGFR Mutation-Positive Stage IV NSCLC: Phase 1b Outcomes
Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2228-S2229
2017
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a/b trial
The lancet oncology, 2019-08, Vol.20 (8), p.1109-1123
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability
Cancer research (Chicago, Ill.), 2019-04, Vol.79 (7), p.1465-1479
2019
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab
British journal of cancer, 2021-04, Vol.124 (8), p.1388-1397
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
JHEP reports, 2021-04, Vol.3 (2), p.100215-100215, Article 100215
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha‐fetoprotein after sorafenib in REACH and REACH‐2
Liver international, 2020-08, Vol.40 (8), p.2008-2020
2020
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation
Proceedings of the National Academy of Sciences - PNAS, 2014-01, Vol.111 (4), p.E484-E491
2014
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab in patients with advanced hepatocellular carcinoma and elevated α‐fetoprotein: Outcomes by treatment‐emergent ascites
Hepatology research, 2021-06, Vol.51 (6), p.715-721
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Prognostic and Predictive Factors in Patients with Advanced HCC and Elevated Alpha-Fetoprotein Treated with Ramucirumab in Two Randomized Phase III Trials
Clinical cancer research, 2022-06, Vol.28 (11), p.2297-2305
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2
The oncologist (Dayton, Ohio), 2022-12, Vol.27 (12), p.e938-e948
2022
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
Liver international, 2021-03, Vol.41 (3), p.598-607
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)
Liver cancer (Basel ), 2021-09, Vol.10 (5), p.451-460
2021
Volltextzugriff (PDF)
Open Access
    Datensatz exportieren als...
  • BibTeX
Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology
Liver international, 2021-11, Vol.41 (11), p.2759-2767
2021
Volltextzugriff (PDF)
    Datensatz exportieren als...
  • BibTeX
Prognostic and predictive factors in patients treated with ramucirumab (RAM) with advanced hepatocellular carcinoma (aHCC) and elevated alpha-fetoprotein (AFP): Results from two phase III trials
Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4146-4146
2021
Volltextzugriff (PDF)
1 – 25 von 32
Suche als RSS-Feed
Suchergebnisse filtern
Filter anzeigen